Wednesday

5 July 2017

Time/Venue Event
08:30 – 16:00
Purbeck Lounge

Patient Charity Collaboration

More details to follow

08:30 – 10:00
Solent Hall

Pelvic Floor Symposium

Chairs: Søren Laurberg (Denmark), Asha Senapati (UK)

  • Surgery for rectal prolapse – Steven Brown (UK) 08:30 – 09:00
  • Bowel function after laparoscopic posterior sutured rectopexy versus ventral mesh rectopexy for rectal prolapse a double blind, randomised single-centre study – Lilli Lundby (Denmark) 09:00 – 09:30
  • Discussion – Steven Brown (UK), Lilli Lundby (Denmark) 09:30 – 10:00
08:30 – 10:30
Tregonwell Hall
Delphi Research Session on Gastrointestinal Recovery
09:00 – 10:30
Bay View Suite

So You Think You Know About Oncology?

Organised by: Harpreet Wasan (UK) Oncology Representative on ACPGBI Council

10:00 – 10:30
Solent Hall

Keynote Lecture: Sacral Nerve Stimulation (SNS) – Is it All in the Brain?

Chair: Andy Williams (UK) Chair of The Pelvic Floor Society

Speaker: Peter Christensen (Denmark)

10:30 – 11:00
Windsor Hall
Coffee Break in the Exhibition Hall
11:00 – 13:00
Solent Hall

Advanced and Complex Cancer SymposiumMedtronic: Further, Together

Chairs:  Simon Bach (UK), Tom Cecil (UK), Harpreet Wasan (UK) ACPGBI Oncology Representative

  • Should the primary tumour be resected in patients with unresectable metastatic colorectal cancer?” – Miriam Koopman (Netherlands) 11:00 – 11:15
  • Optimising decision-making and timing of surgical procedures in liver-limited Stage IV cancer – Stephen Fenwick (UK) 11:15 – 11:30
  • Managing peritoneal metastases – the role of cytoreductive surgery & HIPEC – Vic Verwaal (Denmark) 11:30 – 11:45
  • Panel discussion: Stephen Fenwick (UK), Miriam Koopman (Netherlands), Viv Verwaal (Denmark) 11:45 – 11:55
  • Optimising clear resection margins: surgical approaches to locally advanced primary rectal cancer – Torbjörn Holm (Sweden) 11:55 – 12:10
  • Directions of travel in exenterative surgery for advanced rectal cancer – Paris Tekkis (UK) 12:10 – 12:25
  • Surgery for recurrent rectal cancer – the role of the complex cancer clinic – Ian Jenkins (UK) 12:25 – 12:40
  • Panel discussion: Torbjörn Holm (Sweden), Ian Jenkins (UK), Paris Tekkis (UK) 12:40 – 12:50
  • ACPGBI IMPACT initiative in advanced colorectal cancer – Nicola Fearnhead (UK) Chair of ACPGBI Research & Audit Committee  12:50 – 13:00
11:00 – 12:40
Tregonwell Hall

Pelvic Floor Papers

Chairs: Mark Mercer-Jones (UK), Karen Telford (UK)

  • O37: Successful treatment of passive faecal incontinence in an animal model using engineered bioSphincters: A 12 month follow-up study – Jaime Bohl (UK) 11:00 – 11:10
  • O38: Evaluation of fast-fill anal acoustic reflectometry: a more physiological assessment of anal sphincter function? – Nick Heywood (UK) 11:10 – 11:20
  • O39: Anal acoustic reflectometry (AAR): The effect of a rectal balloon catheter on the measurement parameters – Nick Heywood (UK) 11:20 – 11:30
  • O40: Too many cases of anal incontinence (AI) from obstetric anal sphincter injuries (OASIS) are due to missed third and fourth degree tears – Michael Keighley (UK) 11:30 – 11:40
  • O41: Surgical intervention in functional bowel disease. A single centre experience – Usman Khan (UK) 11:40 – 11:50
  • O42: A single centre experience of a specialist nurse-run functional bowel clinic – Samrait Basrai (UK) 11:50 – 12:00
  • O43: Are bowel transit studies more likely to be performed unnecessarily if requested by a non-specialist? – Jakub Chmelo (UK) 12:00 – 12:10
  • O44: Dynamic graciloplasty (DGP) for faecal incontinence: long-term follow up – Rachel French (UK) 12:10 – 12:20
  • O45: Can faecal calprotectin be used as a Screening tool in patients with simple perianal abscesses to pick up asymptomatic Crohn’s’ disease? – Anil George (UK) 12:20 – 12:30
  • O46: Multicenter prospective series of sacral nerve stimulation (SNS) for fecal incontinence in Latin America: initial report – Lucia Oliveira (USA) 12:30 – 12:40
11:00 – 13:00
Bay View Suite

Patient and Researcher: Coming together to achieve successBDRF

Patient Liaison Group and Bowel Disease Research Foundation

Chair: Robert Arnott (UK)

13:00 – 14:00
Windsor Hall
Lunch in the Exhibition Hall
14:00 – 14:15
Solent Hall
Presidential Handover
14:15 – 16:00
Solent Hall

Anastomosis Symposium

Chairs: Nicola Fearnhead (UK), Charles Maxwell-Armstrong (UK), Gillian Tierney (UK)

  • Impact of personality and situation on decision-making about anastomosis and diversion – Susan Moug (UK) 14:15 – 14:30
  • Leak rates following colonic cancer resection: a national perspective – Peter-Martin Krarup (Denmark) 14:30 – 14:45
  • How to measure anastomotic leaks in your hospital by using local quality improvement initiatives – Rob Bethune (UK) 14:45 – 15:00
  • Time to closure of diverting ileostomy: data from the National Bowel Cancer Audit – James Hill (UK) 15:00 – 15:15
  • Avoiding delayed closure of diverting ileostomy: lessons from the EASY trial – Eva Angenete (Sweden) 15:15 – 15:30
  • Minimising colorectal anastomotic leaks – future horizons for prevention – David Jayne (UK) 15:30 – 15:45
  • Discussion 15:45 – 16:00
14:15 – 16:00
Tregonwell Hall

Reconstructing the Anus

Chairs: Søren Laurberg (Denmark), Andy Williams (UK) Chair of The Pelvic Floor Society

  • Is anal sphincter repair dead? (place of extended repair in the age of neuromodulation?) – Robin Phillips (UK) 14:15 – 14:32
  • Enter Magneto – results of the Fennix procedure – Anders Mellgren (USA) 14:32 – 14:49
  • Gatekeeper or keymaster? (SphinKeeper new implantable device) – Pasquale Giordano (UK) 14:49 – 15:06
  • Cell therapies and tissue engineering approaches – Richard Day (UK) 15:06 – 15:23
  • Why repair when we have neuromodulation? And the ICS algorithm – Charles Knowles (UK) 15:23- 15:40
  • Panel discussion 15:40 – 16:00
16:00 Close of Meeting